What Is Retatrutide?
The triple agonist explained — mechanism and lab handling.
Home › Comparisons › GLP-1 Peptides Compared
Comparison
GLP-1 Peptides Compared
Single, dual, triple — the three most-studied GLP-1 research peptides side by side, in plain English.
Semaglutide, tirzepatide, and retatrutide are the three peptides driving most of the current interest in GLP-1 metabolic research. They are often lumped together, but they sit on a clear progression — and the easiest way to tell them apart is to count receptors.
Research use only. This article is an educational comparison of investigational compounds. It is not medical advice, makes no treatment or dosing recommendations, and does not describe human use.
The one-line map
Semaglutide hits one receptor, tirzepatide two, retatrutide three — that is the simplest way to place the three.
The three at a glance
| Compound | Type | Receptors |
|---|---|---|
| Semaglutide | Single agonist | GLP-1 |
| Tirzepatide | Dual agonist | GLP-1 + GIP |
| Retatrutide | Triple agonist | GLP-1 + GIP + glucagon |
Semaglutide — the single agonist
Semaglutide activates the GLP-1 receptor, the single most-studied pathway of the three. It is the baseline the others build on. Full detail: what is semaglutide.
Tirzepatide — the dual agonist
Tirzepatide adds a second incretin target, the GIP receptor, alongside GLP-1. Full detail: what is tirzepatide.
Retatrutide — the triple agonist
Retatrutide adds a third target, the glucagon receptor, on top of GLP-1 and GIP — the reason it is described as the next step beyond the other two. Full detail: what is retatrutide.
Does more receptors mean “better”?
No — not automatically. Newer and more receptors is a description of mechanism, not a quality ranking. Each of the three is its own compound with its own research profile, and they are studied for different reasons. More targets simply means a compound acts on more pathways at once.
How are they handled in the lab?
All three arrive as lyophilized (freeze-dried) powders and are handled the same way: keep the sealed vial cool, dry, and out of light; reconstitute with bacteriostatic water (see how to reconstitute peptides); then refrigerate the solution, where it stays stable for weeks.
Why purity matters either way
Whichever you study, knowing exactly what is in the vial is everything. A reputable source provides a Certificate of Analysis (COA) showing third-party HPLC purity and mass-spec identity for that specific batch — see what is a COA.
Where to buy
Sourcing research-grade GLP-1 peptides
We recommend Vital Chems for tested semaglutide, tirzepatide, retatrutide, and bacteriostatic water.
- Third-party HPLC tested — COA on every order
- Same-day shipping before 1:30 PM PT
- US-based, fast and responsive support
Frequently asked questions
Which targets the most receptors?
Retatrutide, with three (GLP-1, GIP, and glucagon). Tirzepatide targets two (GLP-1 and GIP), and semaglutide targets one (GLP-1).
Is retatrutide better than semaglutide or tirzepatide?
Not inherently. Targeting more receptors describes how a compound works, not how “good” it is. Each is a distinct compound studied for different research reasons.
How are they handled in the lab?
All three ship as freeze-dried powders, are kept cool and dry, reconstituted with bacteriostatic water, and refrigerated after reconstitution.
Are they for human use?
No. All three are investigational and supplied strictly for research use only, not for human or animal consumption.